Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.00
-0.23 (-2.25%)
Mar 3, 2026, 4:00 PM EST - Market closed
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $569.64 million as of March 4, 2026. Its market cap has increased by 153.41% in one year.
Market Cap
569.64M
Enterprise Value
365.41M
1-Year Change
153.41%
Ranking
Category
Stock Price
$10.00
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $569.64M, a decrease of -74.18%. That is a compound annual growth rate of -23.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 582.74M | 9.06% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | 2.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 634.46M |
| Rigel Pharmaceuticals | 627.67M |
| MeiraGTx Holdings | 612.54M |
| YD Bio | 608.27M |
| LB Pharmaceuticals | 601.61M |
| Allogene Therapeutics | 601.15M |
| Replimune Group | 587.92M |
| CorMedix | 568.46M |